采纳股份（301122）8月8日主力资金净流出1355.02万元

Core Points - The stock price of Canar Co., Ltd. (301122) closed at 24.09 yuan on August 8, 2025, with a 1.6% increase and a turnover rate of 6.02% [1] - The company reported a total revenue of 72.71 million yuan for Q1 2025, a year-on-year decrease of 34.28%, and a net profit attributable to shareholders of 7.68 million yuan, down 69.34% year-on-year [1] - Canar Co., Ltd. was established in 2004 and is primarily engaged in the pharmaceutical manufacturing industry, with a registered capital of 1.22 billion yuan [2] Financial Performance - The latest financial report indicates a significant decline in performance, with a net profit decrease of 69.34% and a non-recurring net profit decrease of 78.81% [1] - The liquidity ratios are strong, with a current ratio of 9.215 and a quick ratio of 8.400, while the debt-to-asset ratio stands at 7.51% [1] Investment and Intellectual Property - Canar Co., Ltd. has made investments in 7 companies and participated in 20 bidding projects [2] - The company holds 49 trademark registrations and 93 patents, along with 56 administrative licenses [2]